$AXDX
Accelerate Diagnostics, Inc

2023 Q4 Form 10-Q Financial Statement

#000162828023038327 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q4
Revenue $3.027M $3.299M $2.973M
YoY Change 1.82% 11.45% -11.09%
Cost Of Revenue $2.394M $3.192M $2.131M
YoY Change 12.34% 45.75% -1.39%
Gross Profit $633.0K $100.0K $842.0K
YoY Change -24.82% -87.01% -125.38%
Gross Profit Margin 20.91% 3.03% 28.32%
Selling, General & Admin $5.793M $7.761M $8.771M
YoY Change -33.95% -5.98% -23.68%
% of Gross Profit 915.17% 7761.0% 1041.69%
Research & Development $5.570M $6.996M $6.030M
YoY Change -7.63% -3.97% 31.03%
% of Gross Profit 879.94% 6996.0% 716.15%
Depreciation & Amortization $820.0K $315.0K $793.0K
YoY Change 3.4% -17.32% 23.33%
% of Gross Profit 129.54% 315.0% 94.18%
Operating Expenses $11.36M $14.76M $14.80M
YoY Change -23.23% -5.04% -8.03%
Operating Profit -$10.73M -$14.65M -$13.96M
YoY Change -23.14% -0.81% -28.08%
Interest Expense -$1.756M $15.67M -$705.0K
YoY Change 149.08% -1797.62% -78.04%
% of Operating Profit
Other Income/Expense, Net $52.00K $15.69M -$21.00K
YoY Change -347.62% -1778.18% -76.4%
Pretax Income -$12.43M $1.041M -$14.69M
YoY Change -15.33% -106.63% -35.47%
Income Tax $564.0K $131.0K -$77.00K
% Of Pretax Income 12.58%
Net Earnings -$13.00M $910.0K -$14.61M
YoY Change -11.03% -105.79% -35.93%
Net Earnings / Revenue -429.4% 27.58% -491.39%
Basic Earnings Per Share $0.06 -$0.14
Diluted Earnings Per Share -$0.89 $0.06 -$0.14
COMMON SHARES
Basic Shares Outstanding 14.55M shares 14.37M shares 99.10M shares
Diluted Shares Outstanding 14.55M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.22M $20.16M $45.56M
YoY Change -70.99% -63.6% -28.38%
Cash & Equivalents $12.14M $20.16M $34.91M
Short-Term Investments $1.081M $0.00 $10.66M
Other Short-Term Assets $5.315M $3.638M $2.025M
YoY Change 162.47% 84.3% 29.97%
Inventory $3.310M $3.553M $5.194M
Prepaid Expenses $380.0K $1.435M $818.0K
Receivables $2.622M $2.666M $2.416M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $24.47M $32.44M $56.01M
YoY Change -56.32% -51.05% -23.61%
LONG-TERM ASSETS
Property, Plant & Equipment $5.084M $2.609M $3.478M
YoY Change 46.18% -27.95% -35.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.816M $1.113M $1.242M
YoY Change 46.22% -31.42% -31.65%
Total Long-Term Assets $6.900M $6.881M $9.001M
YoY Change -23.34% -28.14% -7.36%
TOTAL ASSETS
Total Short-Term Assets $24.47M $32.44M $56.01M
Total Long-Term Assets $6.900M $6.881M $9.001M
Total Assets $31.37M $39.32M $65.02M
YoY Change -51.76% -48.15% -21.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.796M $4.812M $4.501M
YoY Change 6.55% 70.7% 126.98%
Accrued Expenses $4.384M $3.437M $2.682M
YoY Change 63.46% -20.07% -5.99%
Deferred Revenue $1.545M $596.0K $547.0K
YoY Change 182.45% 13.74% 21.29%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.309M $726.0K $57.53M
YoY Change -97.72% 807.5% 71807.5%
Total Short-Term Liabilities $12.03M $37.79M $66.56M
YoY Change -81.92% 294.92% 858.34%
LONG-TERM LIABILITIES
Long-Term Debt $36.36M $33.60M $17.64M
YoY Change 106.15%
Other Long-Term Liabilities $2.856M $1.068M $874.0K
YoY Change 226.77% 40.71% 8.17%
Total Long-Term Liabilities $39.22M $1.068M $874.0K
YoY Change 4387.41% 40.71% 8.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.03M $37.79M $66.56M
Total Long-Term Liabilities $39.22M $1.068M $874.0K
Total Liabilities $51.25M $74.36M $87.28M
YoY Change -41.28% -13.18% -26.11%
SHAREHOLDERS EQUITY
Retained Earnings -$668.9M -$655.9M -$607.2M
YoY Change 10.16% 10.7% 6.4%
Common Stock $694.6M $666.3M $630.3M
YoY Change 10.2% 6.12% 8.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$19.89M -$35.03M -$22.26M
YoY Change
Total Liabilities & Shareholders Equity $31.37M $39.32M $65.02M
YoY Change -51.76% -48.15% -21.71%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q4
OPERATING ACTIVITIES
Net Income -$13.00M $910.0K -$14.61M
YoY Change -11.03% -105.79% -35.93%
Depreciation, Depletion And Amortization $820.0K $315.0K $793.0K
YoY Change 3.4% -17.32% 23.33%
Cash From Operating Activities -$7.755M -$8.251M -$9.550M
YoY Change -18.8% -39.21% -20.06%
INVESTING ACTIVITIES
Capital Expenditures $110.0K $755.0K $108.0K
YoY Change 1.85% 75400.0% -126.93%
Acquisitions
YoY Change
Other Investing Activities $0.00 $405.0K $5.950M
YoY Change -100.0% -97.43% -353.3%
Cash From Investing Activities -$110.0K -$350.0K $5.842M
YoY Change -101.88% -102.22% -312.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 107.0K -818.0K -126.0K
YoY Change -184.92% -102.55% -100.67%
NET CHANGE
Cash From Operating Activities -7.755M -8.251M -9.550M
Cash From Investing Activities -110.0K -350.0K 5.842M
Cash From Financing Activities 107.0K -818.0K -126.0K
Net Change In Cash -7.758M -9.419M -3.834M
YoY Change 102.35% -127.5% -191.42%
FREE CASH FLOW
Cash From Operating Activities -$7.755M -$8.251M -$9.550M
Capital Expenditures $110.0K $755.0K $108.0K
Free Cash Flow -$7.865M -$9.006M -$9.658M
YoY Change -18.56% -33.65% -16.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
28000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-655900000 usd
us-gaap Net Income Loss
NetIncomeLoss
-48600000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32400000 usd
CY2023Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1000000 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-29000 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-50000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2025000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
32443000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
56014000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2609000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3478000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1807000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2422000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1352000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1859000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1113000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1242000 usd
CY2023Q3 us-gaap Assets
Assets
39324000 usd
CY2022Q4 us-gaap Assets
Assets
65015000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4812000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4501000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3437000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2682000 usd
CY2023Q3 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
1186000 usd
CY2022Q4 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
472000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
596000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
547000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
726000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
56413000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
468000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1113000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
963000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
829000 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
25598000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
37786000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
66557000 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
270000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
782000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
816000 usd
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
3638000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1545000 usd
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1090000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1068000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
874000 usd
CY2023Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
0 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
663000 usd
CY2023Q3 us-gaap Senior Long Term Notes
SeniorLongTermNotes
0 usd
CY2022Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
16858000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3954546 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3954546 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14504695 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 axdx Gain Loss On Fair Value Adjustment
GainLossOnFairValueAdjustment
18056000 usd
CY2022Q3 axdx Gain Loss On Fair Value Adjustment
GainLossOnFairValueAdjustment
0 usd
axdx Gain Loss On Fair Value Adjustment
GainLossOnFairValueAdjustment
13026000 usd
axdx Gain Loss On Fair Value Adjustment
GainLossOnFairValueAdjustment
0 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-428000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-261000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-170000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-221000 usd
CY2023Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
246000 usd
CY2022Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
73000 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
921000 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
151000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-29000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-49000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
56000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-206000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15691000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-935000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5036000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
961000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1041000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15896000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48334000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47884000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
131000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
286000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
910000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-15896000 usd
us-gaap Net Income Loss
NetIncomeLoss
-48620000 usd
us-gaap Net Income Loss
NetIncomeLoss
-47884000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.21
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14433000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11777000 shares
us-gaap Net Income Loss
NetIncomeLoss
-48620000 usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.21
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14553000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8701000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11777000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7705000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
910000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-15896000 usd
us-gaap Net Income Loss
NetIncomeLoss
-47884000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
48000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-84000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
293000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
139000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
12000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-101000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1203000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15709000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48580000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48069000 usd
us-gaap Net Income Loss
NetIncomeLoss
-48620000 usd
us-gaap Net Income Loss
NetIncomeLoss
-47884000 usd
us-gaap Depreciation
Depreciation
2434000 usd
us-gaap Depreciation
Depreciation
2207000 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
0 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-94000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4023000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8179000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-134000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-74000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
61000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-206000 usd
axdx Gain Loss On Fair Value Adjustment
GainLossOnFairValueAdjustment
13026000 usd
axdx Gain Loss On Fair Value Adjustment
GainLossOnFairValueAdjustment
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
1184000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
0 usd
us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
174000 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
194000 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-49000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32441000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39178000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
925000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
446000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
27506000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9695000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
34527000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8770000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6575000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
184000 usd
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
10000000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
3731000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
192000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
6000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31756000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-64000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-911000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38987000 usd
axdx Inventory Transferredto Fixed Assets
InventoryTransferredtoFixedAssets
-78000 usd
us-gaap Notes Reduction
NotesReduction
25363000 usd
us-gaap Notes Reduction
NotesReduction
29847000 usd
axdx Noncash Or Part Noncash Exchange Of Notes
NoncashOrPartNoncashExchangeOfNotes
56893000 usd
axdx Noncash Or Part Noncash Exchange Of Notes
NoncashOrPartNoncashExchangeOfNotes
0 usd
axdx Debt Discount Premium Notes Issued
DebtDiscountPremiumNotesIssued
6023000 usd
axdx Derivative Liability Additions
DerivativeLiabilityAdditions
38160000 usd
axdx Noncash Or Part Noncash Debt Extinguishment
NoncashOrPartNoncashDebtExtinguishment
0 usd
axdx Noncash Or Part Noncash Debt Extinguishment
NoncashOrPartNoncashDebtExtinguishment
49624000 usd
us-gaap Notes Issued1
NotesIssued1
0 usd
us-gaap Notes Issued1
NotesIssued1
16024000 usd
axdx Warrants Issued
WarrantsIssued
0 usd
axdx Warrants Issued
WarrantsIssued
3753000 usd
axdx Derivative Liability Extinguishment
DerivativeLiabilityExtinguishment
380000 usd
axdx Derivative Liability Extinguishment
DerivativeLiabilityExtinguishment
0 usd
axdx Issuance Of Common Stock In Connection With Extinguishment Of Notes
IssuanceOfCommonStockInConnectionWithExtinguishmentOfNotes
658000 usd
axdx Issuance Of Common Stock In Connection With Extinguishment Of Notes
IssuanceOfCommonStockInConnectionWithExtinguishmentOfNotes
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
2214000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-35033000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-9988000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-35033000 usd
CY2023Q3 axdx Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
-5300000 usd
CY2023Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
21200000 usd
axdx Increase Decrease In Cash Cash Equivalents And Short Term Investments
IncreaseDecreaseInCashCashEquivalentsAndShortTermInvestments
-24400000 usd
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
45600000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s condensed consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions relate to accounts receivable, inventory, property and equipment, accrued liabilities, warranty liabilities, derivatives/fair value of financial instruments, convertible notes, tax valuation accounts, equity-based compensation, warrants, revenue and leases. Actual results could differ materially from those estimates.</span></div>
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
314000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
150000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
324000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
140000 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
253000 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-12000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
252000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
18000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
20000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
29000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
20000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
547000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
138000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
547000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
138000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
axdx Standard Product Warranty Instruments Term
StandardProductWarrantyInstrumentsTerm
P1Y
axdx Standard Product Warranty Kits And Accessories Term
StandardProductWarrantyKitsAndAccessoriesTerm
P60D
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
182000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
255000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
225000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
139000 usd
CY2023Q3 axdx Standard Product Warranty Accrual Increase Decrease For Warranties Issued And Adjustments
StandardProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssuedAndAdjustments
-3000 usd
CY2022Q3 axdx Standard Product Warranty Accrual Increase Decrease For Warranties Issued And Adjustments
StandardProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssuedAndAdjustments
187000 usd
axdx Standard Product Warranty Accrual Increase Decrease For Warranties Issued And Adjustments
StandardProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssuedAndAdjustments
101000 usd
axdx Standard Product Warranty Accrual Increase Decrease For Warranties Issued And Adjustments
StandardProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssuedAndAdjustments
325000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
6000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
29000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
153000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
51000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
173000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
413000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
173000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
413000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
100000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
600000 usd
us-gaap Gross Profit
GrossProfit
1900000 usd
us-gaap Gross Profit
GrossProfit
2500000 usd
us-gaap Inventory Write Down
InventoryWriteDown
1200000 usd
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
1200000 usd
CY2023Q3 axdx Revenue From Inventory Previously Expensed
RevenueFromInventoryPreviouslyExpensed
100000 usd
axdx Revenue From Inventory Previously Expensed
RevenueFromInventoryPreviouslyExpensed
200000 usd
CY2022Q3 axdx Revenue From Inventory Previously Expensed
RevenueFromInventoryPreviouslyExpensed
100000 usd
axdx Revenue From Inventory Previously Expensed
RevenueFromInventoryPreviouslyExpensed
400000 usd
CY2023Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P1Y
CY2023Q3 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P5Y
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
9728000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
9757000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
29000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
0 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
9757000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
9728000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
0 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
9757000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
0 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
0 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
900000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
61000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-206000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 usd
CY2022Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 usd
CY2023Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1392000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1827000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
504000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2115000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1657000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1252000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3553000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
5194000 usd
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
1200000 usd
us-gaap Inventory Write Down
InventoryWriteDown
1200000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13682000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14299000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11073000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10821000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2609000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3478000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
315000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
381000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1023000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1284000 usd
CY2023Q3 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
2129000 usd
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
2585000 usd
CY2023Q3 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
1223000 usd
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
1209000 usd
CY2023Q3 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
906000 usd
CY2022Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
1376000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
500000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5700000 usd
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
These agreements have between two and four year terms and revenue is recognized as reagents are shipped, typically on a straight-line basis. The remaining balance relates to executed service contracts that begin as warranty periods expire. These service contracts typically provide a one to four year term and revenue is recognized on a straight-line basis.
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
120000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Share Price
SharePrice
7.40
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14433000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8701000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11777000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7705000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14553000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8701000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11777000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7705000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1819000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1276000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1939000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1276000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
540732 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
146.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10979 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
82.65
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
160475 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
135.82
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
379278 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
148.47
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
379278 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
313234 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M21D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y11M1D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
148.47
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
161.19
CY2023Q3 axdx Sharebased Compensation Arrangementby Sharebased Payment Award Options Outstanding Weighted Average Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingWeightedAverageFairValue
90.28
CY2023Q3 axdx Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisable Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
96.99
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1815000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1229000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4023000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8179000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
17000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
69000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
126000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
186000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48300000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
100000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13700000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
100000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13596000 usd
us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
131000 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13727000 usd
CY2023Q3 axdx Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
1100000 usd
CY2022Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
11900000 usd
CY2023Q3 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
11900000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
251000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
219000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
704000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
712000 usd
CY2023Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
816000 usd
CY2022Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
684000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1357000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1109000 usd
CY2023Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q3 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
200000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
2760000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
242000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
254000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
735000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
818000 usd
CY2023Q3 axdx Finance Lease Cost
FinanceLeaseCost
284000 usd
CY2022Q3 axdx Finance Lease Cost
FinanceLeaseCost
240000 usd
axdx Finance Lease Cost
FinanceLeaseCost
816000 usd
axdx Finance Lease Cost
FinanceLeaseCost
462000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
18000 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
26000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
60000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
67000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.071
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.059
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
264000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
88000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1051000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
784000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
583000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
86000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
36000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 usd
CY2023Q3 axdx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2023Q3 axdx Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1898000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
994000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
118000 usd
CY2023Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
256000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1780000 usd
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
738000 usd
CY2023Q3 us-gaap Net Investment In Lease
NetInvestmentInLease
2100000 usd
CY2023Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
382000 usd
CY2023Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
1202000 usd
CY2023Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
603000 usd
CY2023Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
328000 usd
CY2023Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
46000 usd
CY2023Q3 axdx Sales Type And Direct Financing Leases Lease Receivable To Be Received After Year Four
SalesTypeAndDirectFinancingLeasesLeaseReceivableToBeReceivedAfterYearFour
0 usd
CY2023Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
2561000 usd
CY2023Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount
SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount
0 usd
CY2023Q3 axdx Sales Type And Direct Financing Leases Lease Receivable Allowances
SalesTypeAndDirectFinancingLeasesLeaseReceivableAllowances
414000 usd
CY2023Q3 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
2147000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3299000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2960000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9032000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9780000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3299000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2960000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9032000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9780000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3299000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2960000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9032000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9780000 usd
CY2023Q3 us-gaap Lease Income
LeaseIncome
700000 usd
CY2022Q3 us-gaap Lease Income
LeaseIncome
200000 usd
us-gaap Lease Income
LeaseIncome
1300000 usd
us-gaap Lease Income
LeaseIncome
1300000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Share Price
SharePrice
7.40
CY2023Q2 us-gaap Purchase Obligation
PurchaseObligation
933000 usd
CY2022Q2 us-gaap Purchase Obligation
PurchaseObligation
0 usd
CY2022Q4 us-gaap Purchase Obligation
PurchaseObligation
0 usd
CY2021Q4 us-gaap Purchase Obligation
PurchaseObligation
0 usd
CY2023Q3 axdx Purchase Obligation Initial Measurement
PurchaseObligationInitialMeasurement
0 usd
CY2022Q3 axdx Purchase Obligation Initial Measurement
PurchaseObligationInitialMeasurement
0 usd
axdx Purchase Obligation Initial Measurement
PurchaseObligationInitialMeasurement
1336000 usd
axdx Purchase Obligation Initial Measurement
PurchaseObligationInitialMeasurement
0 usd
CY2023Q3 axdx Purchase Obligation Gain Loss In Fair Value
PurchaseObligationGainLossInFairValue
1248000 usd
CY2022Q3 axdx Purchase Obligation Gain Loss In Fair Value
PurchaseObligationGainLossInFairValue
0 usd
axdx Purchase Obligation Gain Loss In Fair Value
PurchaseObligationGainLossInFairValue
845000 usd
axdx Purchase Obligation Gain Loss In Fair Value
PurchaseObligationGainLossInFairValue
0 usd
CY2023Q3 us-gaap Purchase Obligation
PurchaseObligation
2181000 usd
CY2022Q3 us-gaap Purchase Obligation
PurchaseObligation
0 usd
CY2023Q3 us-gaap Purchase Obligation
PurchaseObligation
2181000 usd
CY2022Q3 us-gaap Purchase Obligation
PurchaseObligation
0 usd
CY2023Q2 axdx Common Stock Increase In Shares Authorized
CommonStockIncreaseInSharesAuthorized
250000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares

Files In Submission

Name View Source Status
0001628280-23-038327-index-headers.html Edgar Link pending
0001628280-23-038327-index.html Edgar Link pending
0001628280-23-038327.txt Edgar Link pending
0001628280-23-038327-xbrl.zip Edgar Link pending
a09302023-exh311.htm Edgar Link pending
a09302023-exh312.htm Edgar Link pending
a09302023-exh32.htm Edgar Link pending
axdx-20230930.htm Edgar Link pending
axdx-20230930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
axdx-20230930_cal.xml Edgar Link unprocessable
axdx-20230930_def.xml Edgar Link unprocessable
axdx-20230930_lab.xml Edgar Link unprocessable
axdx-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
axdx-20230930_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending